A detailed history of Princeton Capital Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Princeton Capital Management LLC holds 10,192 shares of ABBV stock, worth $1.89 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares
10,192
Previous 10,267 0.73%
Holding current value
$1.89 Million
Previous $1.59 Million 16.59%
% of portfolio
0.68%
Previous 0.65%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$159.82 - $182.1 $11,986 - $13,657
-75 Reduced 0.73%
10,192 $1.86 Million
Q4 2023

Feb 08, 2024

SELL
$137.6 - $154.97 $3.11 Million - $3.51 Million
-22,626 Reduced 68.79%
10,267 $1.59 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $846,827 - $980,326
-6,339 Reduced 16.16%
32,893 $4.9 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $7,818 - $9,729
-59 Reduced 0.15%
39,232 $5.29 Million
Q1 2023

May 01, 2023

SELL
$144.61 - $166.54 $787,112 - $906,477
-5,443 Reduced 12.17%
39,291 $6.26 Million
Q4 2022

Jan 31, 2023

SELL
$138.31 - $165.87 $680,346 - $815,914
-4,919 Reduced 9.91%
44,734 $7.23 Million
Q3 2022

Nov 10, 2022

SELL
$134.21 - $153.93 $12,347 - $14,161
-92 Reduced 0.18%
49,653 $6.66 Million
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $113,949 - $144,866
828 Added 1.69%
49,745 $7.62 Million
Q1 2022

May 11, 2022

SELL
$131.98 - $163.75 $74,172 - $92,027
-562 Reduced 1.14%
48,917 $7.93 Million
Q4 2021

Feb 09, 2022

BUY
$107.43 - $135.93 $6,338 - $8,019
59 Added 0.12%
49,479 $6.7 Million
Q3 2021

Nov 10, 2021

BUY
$106.4 - $120.78 $18,726 - $21,257
176 Added 0.36%
49,420 $5.33 Million
Q2 2021

Aug 11, 2021

BUY
$105.21 - $117.21 $6,417 - $7,149
61 Added 0.12%
49,244 $5.55 Million
Q1 2021

May 12, 2021

BUY
$102.3 - $112.62 $19,641 - $21,623
192 Added 0.39%
49,183 $5.32 Million
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $132,728 - $179,196
1,649 Added 3.48%
48,991 $5.25 Million
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $103,435 - $121,399
1,204 Added 2.61%
47,342 $4.15 Million
Q2 2020

Aug 10, 2020

BUY
$73.37 - $98.18 $134,413 - $179,865
1,832 Added 4.13%
46,138 $4.53 Million
Q1 2020

May 13, 2020

BUY
$64.5 - $97.79 $153,832 - $233,229
2,385 Added 5.69%
44,306 $3.79 Million
Q4 2019

Feb 12, 2020

BUY
$72.13 - $90.25 $12,045 - $15,071
167 Added 0.4%
41,921 $3.87 Million
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $105,806 - $127,209
-1,680 Reduced 3.87%
41,754 $3.16 Million
Q2 2019

Aug 12, 2019

SELL
$65.7 - $83.98 $67,671 - $86,499
-1,030 Reduced 2.32%
43,434 $3.16 Million
Q1 2019

May 02, 2019

BUY
$77.14 - $90.79 $932,236 - $1.1 Million
12,085 Added 37.32%
44,464 $3.58 Million
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $871,219 - $1.07 Million
-11,191 Reduced 25.69%
32,379 $2.99 Million
Q3 2018

Nov 08, 2018

BUY
$88.91 - $98.84 $1.55 Million - $1.73 Million
17,472 Added 66.95%
43,570 $4.12 Million
Q2 2018

Aug 02, 2018

BUY
$89.78 - $106.23 $86,637 - $102,511
965 Added 3.84%
26,098 $2.42 Million
Q1 2018

May 03, 2018

SELL
$92.01 - $123.21 $124,397 - $166,579
-1,352 Reduced 5.1%
25,133 $2.38 Million
Q4 2017

Feb 12, 2018

BUY
$89.56 - $98.21 $2.37 Million - $2.6 Million
26,485
26,485 $2.56 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $327B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Princeton Capital Management LLC Portfolio

Follow Princeton Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Princeton Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Princeton Capital Management LLC with notifications on news.